Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127922) titled 'A multicenter, prospective, observational, real-world cohort study evaluating the efficacy and safety of lecanemab combined with rivastigmine transdermal patch compared to lecanemab monotherapy in early Alzheimer's disease' on July 9.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Fujian Medical University Union Hospital
Condition:
Alzheimers disease
Intervention:
Combination therapy cohort (treated with lecanemumab combined with Lisi's transdermal patch):None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-15
Target Sample Size: Combinati...